02.05.2017 14:00:34
|
Bio-Techne Q3 Profit Declines, But Results Beat View - Quick Facts
(RTTNews) - Bio-Techne Corp. (TECH) on Tuesday reported a decline in profit for the third quarter from last year, as higher sales were more than offset by an increase in expenses.
The company's net income for the third quarter decreased to $21.39 million or $0.57 per share from $30.29 million or $0.81 per share in the same quarter last year.
The latest quarter's results were impacted by acquisition-related amortization, contingent consideration fair value adjustments, and other acquisition related costs.
Adjusted earnings per share were $0.97, compared to $1.01 per share in the same quarter last year. On average, 8 analysts polled by Thomson Reuters expected the company to report earnings of $0.93 per share. Analysts' estimates typically exclude special items.
Net sales for the third quarter increased 10 percent to $144.04 million from $130.97 million in the year-ago period. Organic growth was 4 percent compared to the prior year. Analysts had a consensus revenue estimate of $142.74 million.
Bio-Techne also said that its board of directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2017.
The quarterly dividend will be payable June 2, 2017 to all common shareholders of record on May 19, 2017. Future cash dividends will be considered by the board on a quarterly basis.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bio-Techne Corpmehr Nachrichten
13.02.25 |
S&P 500-Papier Bio-Techne-Aktie: Wäre eine Bio-Techne-Kapitalanlage von vor einem Jahr lukrativ gewesen? (finanzen.at) | |
10.02.25 |
Börse New York: S&P 500 liegt schlussendlich im Plus (finanzen.at) | |
10.02.25 |
Starker Wochentag in New York: S&P 500 verbucht Gewinne (finanzen.at) | |
10.02.25 |
Aufschläge in New York: Börsianer lassen S&P 500 am Montagmittag steigen (finanzen.at) | |
10.02.25 |
Handel in New York: S&P 500 bewegt sich zum Start im Plus (finanzen.at) | |
06.02.25 |
S&P 500-Titel Bio-Techne-Aktie: So viel Gewinn hätte ein Bio-Techne-Investment von vor 10 Jahren eingefahren (finanzen.at) | |
05.02.25 |
Verluste in New York: S&P 500 zum Handelsstart in Rot (finanzen.at) | |
04.02.25 |
Ausblick: Bio-Techne vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |
Analysen zu Bio-Techne Corpmehr Analysen
Aktien in diesem Artikel
Bio-Techne Corp | 62,50 | 0,81% |
|